Qorvo price target lowered to $85 from $90 at Mizuho
Mizuho analyst Vijay Rakesh lowered the firm’s price target on Qorvo (QRVO) to $85 from $90 and keeps a Neutral rating on the shares. The firm ...
H.C. Wainwright maintains $80 target on Corcept Therapeutics stock
H.C. Wainwright reiterated its Buy rating and $80.00 price target for Corcept Therapeutics (NASDAQ:CORT), highlighting the company's consistent growth in Korlym sales over the past eight quarters ...